Skip to main content

Cytomyx Buys Tissue Bank Business from Ardais for $3M

NEW YORK, March 30 (GenomeWeb News) - Cytomyx has bought the tissue bank business from Ardais for $3 million in cash, the Cambridge, UK-based company said today.


Cytomyx purchased the newly formed subsidiary of Lexington, Mass.-based Ardais, called Biorepository Business. The subsidiary includes a tissue bank of more than 130,000 human tissue samples with clinical information, primarily from cancer patients. The business also offers tissue microarray and other molecular products as well as immunohistochemistry services. Last year, the business unit had $3.7 million in revenues.


Following the acquisition, Cytomyx will relocate its current USbiorepository facility and key personnel from Albany, New York, to Ardais' Lexingtonfacility. Cytomyx will also gain access to Ardais' web-searchable biospecimen management system.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.